It depends when the dust settles and they can emerge from b/k and/or any possible deal with a larger pharma company. Currently they have very little debt so this is a major roadblock out of the way to come out from b/k and what the plans with Cytovia would be. The total O/S is app/ or less than 190 millions. So, I would venture to say that at least a pps range of $1 - 10.00 depending how the market sees it... ! Have seen a few small pharma companies going from pennies to double digits pps this year so far... !
Wondering where the others are .... probably under a "gag order", which is, if you speak I cut your tongue.... !! LOL
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.